Search research articles
Contact Us
Filters
Showing results (11-20 of 113) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2005
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group
S Vincent Rajkumar, Emily Blood, David Vesole, et al.
Mayo Clinic Proceedings
|
August 14, 2002
Current therapy for multiple myeloma
S Vincent Rajkumar, Morie A Gertz, Robert A Kyle, et al.
Blood
|
July 14, 2011
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival
Jeremy T Larsen, Cheng E Chee, John A Lust, et al.
British Journal of Haematology
|
September 16, 2009
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial
Morie A Gertz, Rafat Abonour, Leonard T Heffner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2009
A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97
David H Vesole, Lijun Zhang, Neal Flomenberg, et al.
Experimental Hematology
|
June 21, 2005
PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis
Apollina Goel, Angela Dispenzieri, Philip R Greipp, et al.
Leukemia & Lymphoma
|
September 17, 2004
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98)
Morie A Gertz, Montserrat Rue, Emily Blood, et al.
Clinical Chemistry
|
December 31, 2009
Sharply increased serum free light-chain concentrations after treatment for multiple myeloma
Kazunori Murata, Raynell J Clark, Karen S Lockington, et al.
Leukemia Research
|
February 27, 2009
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group
Martha Q Lacy, Susanna Jacobus, Emily A Blood, et al.
British Journal of Haematology
|
March 6, 2008
Anti-CD20 monoclonal antibody therapy in multiple myeloma
Prashant Kapoor, Patricia T Greipp, William G Morice, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 113) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 21, 2005
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group
S Vincent Rajkumar, Emily Blood, David Vesole, et al.
Mayo Clinic Proceedings
|
August 14, 2002
Current therapy for multiple myeloma
S Vincent Rajkumar, Morie A Gertz, Robert A Kyle, et al.
Blood
|
July 14, 2011
Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival
Jeremy T Larsen, Cheng E Chee, John A Lust, et al.
British Journal of Haematology
|
September 16, 2009
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial
Morie A Gertz, Rafat Abonour, Leonard T Heffner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 13, 2009
A Phase II trial of autologous stem cell transplantation followed by mini-allogeneic stem cell transplantation for the treatment of multiple myeloma: an analysis of Eastern Cooperative Oncology Group ECOG E4A98 and E1A97
David H Vesole, Lijun Zhang, Neal Flomenberg, et al.
Experimental Hematology
|
June 21, 2005
PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis
Apollina Goel, Angela Dispenzieri, Philip R Greipp, et al.
Leukemia & Lymphoma
|
September 17, 2004
Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98)
Morie A Gertz, Montserrat Rue, Emily Blood, et al.
Clinical Chemistry
|
December 31, 2009
Sharply increased serum free light-chain concentrations after treatment for multiple myeloma
Kazunori Murata, Raynell J Clark, Karen S Lockington, et al.
Leukemia Research
|
February 27, 2009
Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): a trial of the Eastern Cooperative Oncology Group
Martha Q Lacy, Susanna Jacobus, Emily A Blood, et al.
British Journal of Haematology
|
March 6, 2008
Anti-CD20 monoclonal antibody therapy in multiple myeloma
Prashant Kapoor, Patricia T Greipp, William G Morice, et al.
Page
of 12